These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24035850)

  • 1. Commentary on "Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma".
    Lewis PD
    Transl Res; 2013 Nov; 162(5):275-8. PubMed ID: 24035850
    [No Abstract]   [Full Text] [Related]  

  • 2. Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma.
    Zhang X; Thiéfin G; Gobinet C; Untereiner V; Taleb I; Bernard-Chabert B; Heurgué A; Truntzer C; Ducoroy P; Hillon P; Sockalingum GD
    Transl Res; 2013 Nov; 162(5):279-86. PubMed ID: 23920432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature.
    Peng C; Kaščáková S; Chiappini F; Olaya N; Sandt C; Yousef I; Samuel D; Dumas P; Guettier C; Le Naour F
    J Transl Med; 2016 Jan; 14():9. PubMed ID: 26754490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for early diagnosis of hepatocellular carcinoma.
    Forner A; Bruix J
    Lancet Oncol; 2012 Aug; 13(8):750-1. PubMed ID: 22738800
    [No Abstract]   [Full Text] [Related]  

  • 5. Dickkopf-1 and hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang WL
    Lancet Oncol; 2012 Oct; 13(10):e410; author reply e410-1. PubMed ID: 23026825
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour markers of hepatocellular carcinoma.
    Kew MC
    J Gastroenterol Hepatol; 1989; 4(4):373-84. PubMed ID: 2562350
    [No Abstract]   [Full Text] [Related]  

  • 8. Early Detection of Hepatocellular Carcinoma in Patients with Hepatocirrhosis by Soluble B7-H3.
    Zhao L; Xie C; Liu D; Li T; Zhang Y; Wan C
    J Gastrointest Surg; 2017 May; 21(5):807-812. PubMed ID: 28243980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
    Trojan J; Raedle J; Zeuzem S
    Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocellular carcinoma tumour markers: current role and expectations.
    Rich N; Singal AG
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Glutamyl transferase and its role as a biomarker of systemic malignancies other than hepatocellular carcinomas.
    Kapoor S
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):387. PubMed ID: 23348021
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma.
    Lu Y; Li N; Gao L; Xu YJ; Huang C; Yu K; Ling Q; Cheng Q; Chen S; Zhu M; Fang J; Chen M; Ong CN
    Cancer Res; 2016 May; 76(10):2912-20. PubMed ID: 26976432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of serum CA125 in patients with hepatocellular carcinoma].
    Ohgi N; Horie Y; Maeda N; Hirayama C
    Nihon Shokakibyo Gakkai Zasshi; 1988 Oct; 85(10):2239-42. PubMed ID: 2850378
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma.
    Han N; Wang W; Lu D; Wang H; Ma X; Fan X; Li F
    Chem Commun (Camb); 2017 Nov; 53(90):12209-12212. PubMed ID: 29077109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
    Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
    Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma.
    Matsuzaki Y; Osuga T; Chiba T; Saito Y; Tanaka N; Itai Y; Tsujii H
    Intern Med; 1995 Apr; 34(4):302-4. PubMed ID: 7606109
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A fibrolamellar variety of hepatocarcinoma in a young woman 17 years old].
    Téllez-Zenteno JF; Hernández-Ronquillo L; Tapia-Rangel B; Garduño-Espinosa J
    Gac Med Mex; 1999; 135(1):83-7. PubMed ID: 10204316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.